BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 20, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Regulatory actions for April 26, 2022

April 26, 2022
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dib Ultranav Medical, Franklin Mountain Medical.
Read More

Other news to note for April 26, 2022

April 26, 2022
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abiomed, Advanced Instruments, Artel, Cathvision, Circassia, Dia Imaging, Intel, Lunit, Myapps, Novacyt, Primerdesign, Shimadzu, Telecure, Tetrascience, Unidoc, Vectorious.
Read More

In the clinic for April 26, 2022

April 26, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Notal Vision.
Read More

Financings for April 26, 2022

April 26, 2022
Med-tech firms raising money in public or private financings, including: Establishment Labs.
Read More

Appointments and advancements for April 26, 2022

April 26, 2022
New hires and promotions in the med-tech industry, including: Antylia, Assure, Let’s Talk, Medcura, Medtronic, Outset Medical, Predictive Oncology.
Read More
Acquisition target

Blackrock Neurotech snaps up Mindx to drive brain-computer interface implants

April 25, 2022
By Meg Bryant
Blackrock Neurotech LLC has acquired spatial computing software startup Mindx Corp. to advance full-stack brain-computer interface (BCI) products. As part of the transaction, Mindx’s augmented reality (AR) and artificial intelligence (AI) technology will be integrated with Blackrock’s BCI hardware.
Read More
Nanobiotix

Nanobiotix presents new preclinical data for its nano-radioenhancer combined with checkpoint inhibitors

April 25, 2022
By Bernard Banga
Nanobiotix SA has just presented new data from an open-label preclinical study evaluating the action of its nanoparticle-enhanced radiotherapy, NBTXR3, with the triple blockade of PD-1, LAG-3, and TIGIT on mice carrying cancerous cells. PD-1, LAG-3 and TIGIT are three checkpoint inhibitors which regulate the natural killer cells usually targeted in combination therapy in immuno-oncology.
Read More
Woman using eyedrops

University of Birmingham spin-off eyes ocular surface disease market

April 25, 2022
By Catherine Longworth
A technology developed at the University of Birmingham, U.K., has been spun off as a potential treatment for ocular surface diseases. The platform technology from startup Healome Therapeutics Ltd. was developed by a team of material scientists at the University’s Healthcare Technologies Institute (HTI) that translates health technology concepts to products for clinical trials.
Read More

Regulatory actions for April 25, 2022

April 25, 2022
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Conextions.
Read More

Cambridge Innovations raises £225M fund amid high interest in university spinouts

April 25, 2022
By Nuala Moran
Cambridge Innovation Capital (CIC) has closed its oversubscribed Fund II at £225 million (US$287 million) and is moving from its previous model of open-ended investing to a traditional fixed-term venture capital fund. The money will be dedicated to spinouts from Cambridge University, with CIC investing in series A rounds, but also following on as companies mature and their capital requirements increase.
Read More
Previous 1 2 … 939 940 941 942 943 944 945 946 947 … 10248 10249 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 19, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Ebola virus particle

    Authorities work to quickly sequence Ebola species in latest outbreak

    BioWorld
    If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
  • Brain, illustrating pain/injury

    Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model

    BioWorld Science
    Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing